CHICAGO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced continued operational growth and infrastructure expansion at Cosmofarm, its pharmaceutical distribution subsidiary in Greece.

D-Wave Quantum Inc. NYSE: QBTS, the $10-billion quantum computing company with a share price that has soared by more than 358% in the last 12 months, is working to position itself as the go-to quantum firm in a crowded field that also includes competitors like IonQ Inc. NYSE: IONQ, Rigetti Computing NASDAQ: RGTI, and others.

The biotech sector is one that's become red-hot, at least in recent years. After around a decade of stagnation, investors appear to be intent on increasing their exposure to top biotech names in the market, as growth in other sectors of the economy have led to valuations that now look more elevated than the biotech sector (in many cases).

GDOT's growth is driven by rising BaaS adoption, new partnerships & AI innovation. Revenues for 2025 and 2026 are likely to witness double-digit growth.

Kinder Morgan's Q4 results may get a boost from higher natural gas pipeline revenues but an earnings beat is unlikely.

CRMD and MIRM are advancing niche therapies with strong launches, rising sales and strategic acquisitions shaping their growth.

The iShares MSCI Emerging Markets ex China ETF (EMXC) offers large and mid-cap emerging market exposure while excluding exposure to China. EMXC has outperformed the broader EEM ETF since inception, largely due to its lack of Chinese equity exposure. TSM represents outsized exposure for EMXC and thus forming a view on this stock is key to forming a view on EMXC.

The small-cap stocks have been flying under the radar of most retail investors amid the magnificent rise of the Magnificent Seven tech giants.

Trade Desk and Magnite tap the same CTV tailwinds, but costs, competition and differing platform roles set up a sharp contrast in risk and reward.

NTRS heads into Q4 earnings with rising estimates. However, elevated expenses and asset quality risks linger.

KeyCorp tops Q4 estimates with higher NII and revenue growth, but stock slips as provisions spike sharply.

Over the past ten years, Alphabet (GOOGL) stock has provided an incredible $357 Bil to its investors in the form of cash through dividends and stock buybacks.

The tech and AI trade has grown a bit chppier in recent years, in some places more than others.

LOS ANGELES, Jan. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Blue Owl Capital Inc. (“Blue Owl” or “the Company”) (NYSE: OWL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 6, 2025 and November 16, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before February 2, 2026.

CRDO posts record Q2 FY26 revenue of $268M, up 272% YoY, as AEC demand surges and AI clusters drive explosive growth.

Looking beyond earnings, stocks like DNOW, PRSU, REPX and RFIL stand out as rising cash flow signals strength to fund growth amid global uncertainty.

NKE and ADDYY show contrasting market share, strategies and earnings trends as the athleticwear industry enters a new phase.

RIVN starts R2 validation builds at its Illinois plant, signaling momentum toward first-half 2026 deliveries of its affordable electric SUV.

DLR's Malaysia entry strengthens its Southeast Asia footprint, adding scalable capacity, dense connectivity and a new hub to support regional digital growth.

Most marijuana stock investors have gotten used to how the sector behaves in certain scenarios. For example, history has shown that political news on reform, mainly in the USA, leads to better trading. As well as news on a company strong enough to move the stock up becuase of it, like strong earnings or a strategic partnership. Right now, there is high speculation on what will occur in 2026. This year is another pivotal one, already bringing many changes to the cannabis industry as a whole.